Heidelberg Pharma AG Profit Margin

Heidelberg Pharma AG (HPHA.DE) currently reports a profit margin of -320.9% as of August 2026. That compares with -861.83% in the prior-year period — up 62.8% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Heidelberg Pharma AG's profit margin history and peer comparisons.

Heidelberg Pharma AG's profit margin increased from -861.83% to -320.9% — a 62.8% year-over-year increase (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Heidelberg Pharma AG's profit margin of -320.9% is lower than the Healthcare sector average of 9.48%. That is roughly 3484.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Heidelberg Pharma AG's current -320.9% should be judged against Healthcare norms (sector average: 9.48%) and against HPHA.DE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -320.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Heidelberg Pharma AG, and consider following HPHA.DE for alerts when major investors trade the stock.